Ovid Therapeutics Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 25.0% | – | – | – | 3,741.3% | 950.6% | 603.0% | 526.4% | 369.2% | 282.7% | 91.9% | 87.6% | 97.7% | – | 218.5% | 1.6% | 12.9% | 6.1% | – | 2.2% | 7.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 0.0% | -25.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 97.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 229.6% | 285.5% | 7.8% | 3.7% | 2,359.8% | – | 541.9% | – | 46,687.6% | 12,005.6% | 10,022.7% | 7,998.7% | 4,892.7% | 7,494.4% | 7,025.0% | 7,445.0% | 4,540.5% | 7,793.4% | 5,122.3% | 103.1% | 4,447.0% | 917.7% | – | 1,358.4% | 2,122.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 107.6% | 182.5% | 7.5% | 3.2% | 3,245.9% | – | 683.6% | – | 68,744.4% | 15,909.6% | 12,642.4% | 9,664.0% | 6,243.1% | 4,357.7% | 4,843.2% | 4,795.3% | 3,204.6% | 8,914.5% | 4,631.5% | 77.8% | 5,140.2% | 894.4% | – | 842.3% | 1,645.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 337.3% | 478.6% | 15.3% | 6.9% | 5,605.9% | – | 1,225.5% | – | 115,429.3% | 26,402.7% | 22,663.6% | 18,996.0% | 11,135.8% | 12,908.5% | 11,868.2% | 12,240.2% | 7,745.1% | 14,207.9% | 9,753.8% | 180.9% | 9,587.1% | 1,812.1% | – | 2,241.6% | 3,786.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -237.3% | -378.6% | 84.7% | -6.9% | -5,605.9% | – | -1,125.5% | – | -115,329.3% | -26,302.7% | -22,563.6% | -18,896.0% | -11,035.8% | -12,808.5% | -11,768.2% | -12,140.2% | -7,645.1% | -14,107.9% | -9,653.8% | -80.9% | -9,487.1% | -1,712.1% | – | -2,141.6% | -3,686.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 14.4% | – | 7,530.9% | 2,286.2% | 2,327,418.2% | – | – | 1,081,757.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -237.6% | -386.3% | 84.7% | -6.9% | -5,604.6% | – | -1,111.0% | – | -107,798.3% | -24,859.1% | -20,236.4% | -16,544.0% | -10,323.9% | -10,790.1% | -7,901.4% | 5,042.0% | -8,096.0% | -12,175.0% | -7,873.1% | -74.7% | -9,210.6% | 1,345.8% | – | -2,047.6% | -2,178.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.2% | 0.7% | -141.5% | – | 3.5% | – | -7,530.2% | -108.0% | -2,327,418.2% | 0.3% | 0.2% | 0.0% | 62.7% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -237.6% | -386.3% | 84.5% | -7.6% | -5,463.1% | – | -1,114.5% | – | -107,798.3% | -24,859.1% | -20,236.4% | -16,544.0% | -10,323.9% | -10,790.1% | -7,901.4% | 5,042.0% | -8,096.0% | -12,175.0% | -7,873.1% | -74.7% | -9,210.6% | 1,345.8% | – | -2,047.6% | -2,178.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -236.1% | -377.1% | 84.8% | -6.8% | -5,580.7% | – | -1,120.3% | – | -111,590.6% | -27,415.6% | -22,345.5% | -17,380.0% | -10,189.9% | -11,512.7% | -7,809.5% | 5,129.6% | -7,998.3% | -14,160.5% | -7,764.6% | -73.1% | -9,198.5% | 1,348.2% | – | -2,098.5% | -2,252.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.